146 related articles for article (PubMed ID: 29860064)
1. Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.
Alsiary R; Brownhill SC; Brüning-Richardson A; Hutson R; Griffin N; Morrison EE; Bond J; Burchill SA; Bell SM
Gene; 2018 Sep; 672():34-44. PubMed ID: 29860064
[TBL] [Abstract][Full Text] [Related]
2. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.
Lin SY; Rai R; Li K; Xu ZX; Elledge SJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15105-9. PubMed ID: 16217032
[TBL] [Abstract][Full Text] [Related]
3. MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene.
Shi L; Li M; Su B
Gene; 2012 Mar; 495(1):1-9. PubMed ID: 22240313
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of MCPH1/BRIT1 in carcinogenesis.
Alsolami M; Aboalola D; Malibari D; Alghamdi T; Alshekhi W; Jad H; Rumbold-Hall R; Altowairqi AS; Bell SM; Alsiary RA
Front Oncol; 2023; 13():1047588. PubMed ID: 36845691
[TBL] [Abstract][Full Text] [Related]
5. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
6. No association between BRCA1 immunohistochemical expression and tumor grade, stage or overall survival in platinum-treated epithelial ovarian cancer patients.
Shawky Ael-A; El-Hafez AA; El-Tantawy D; Hamdy R
Asian Pac J Cancer Prev; 2014; 15(10):4275-9. PubMed ID: 24935384
[TBL] [Abstract][Full Text] [Related]
7. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
[No Abstract] [Full Text] [Related]
8. Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.
Lee YK; Chung HH; Kim JW; Song YS; Park NH
Int J Clin Exp Pathol; 2015; 8(11):14971-6. PubMed ID: 26823830
[TBL] [Abstract][Full Text] [Related]
9. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.
Lincz LF; Mudge LM; Scorgie FE; Sakoff JA; Hamilton CS; Seldon M
Neoplasia; 2008 Oct; 10(10):1131-7. PubMed ID: 18813352
[TBL] [Abstract][Full Text] [Related]
10. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
[TBL] [Abstract][Full Text] [Related]
11. BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.
Giallongo C; Tibullo D; La Cava P; Branca A; Parrinello N; Spina P; Stagno F; Conticello C; Chiarenza A; Vigneri P; Palumbo GA; Di Raimondo F
Acta Haematol; 2011; 126(4):205-10. PubMed ID: 21934293
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
13. Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.
Vo LT; Thuan TB; Thu DM; Uyen NQ; Ha NT; To TV
Asian Pac J Cancer Prev; 2013; 14(12):7713-8. PubMed ID: 24460357
[TBL] [Abstract][Full Text] [Related]
14. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
15. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
16. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2.
May T; Yang J; Shoni M; Liu S; He H; Gali R; Ng SK; Crum C; Berkowitz RS; Ng SW
Neoplasia; 2013 Jun; 15(6):600-8. PubMed ID: 23730208
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
19. Methylation status and immunohistochemistry of BRCA1 in epithelial ovarian cancer.
Pradjatmo H; Dasuki D; Anwar M; Mubarika S; Harijadi
Asian Pac J Cancer Prev; 2014; 15(21):9479-85. PubMed ID: 25422243
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
